CHOCRY Mathieu
Primary tabs
Publications
http://api.archives-ouvertes.fr/search/?&fq=authLastNameFirstName_s:%28%22Chocry+Mathieu%22%29&fl=title_s,en_title_s,docid,label_s,en_label_s,authIdHal_s,halId_s,structId_i,uri_s,keyword_s,en_keyword_s,authLastNameFirstName_s,journalTitle_s,abstract_s,en_abstract_s,producedDate_tdate,producedDateY_i,language_s&sort=publicationDate_s+desc
-
Dosimetric environment of preclinical FLASH hadrontherapy studies at the ARRONAX cyclotron2023
-
Preclinical irradiations at conventional and very high dose rates (FLASH-RT) on small animals at the ARRONAX research cyclotron: repositioning, margins and field sizes2023
-
New Biocompatible β‐Phosphorylated Linear Nitrones Targeting Mitochondria: Protective Effect in Apoptotic CellsChemBioChem2023
-
Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal CancerCancers2022
-
Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular ProfileCancers2020
-
Targeting mitochondria with novel, differently vectorized linear phosphorylated nitrones:2020
-
The NADPH oxidase family and its inhibitorsAntioxidants and Redox Signaling2019
-
Metformin-Derived Hybrid Molecules for Glioblastoma TreatmentProceedings2019
-
Inhibitor of Apoptosis Proteins Determine Glioblastoma Stem-Like Cells Fate in an Oxygen-Dependent MannerSTEM CELLS2019
-
Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathwayOncotarget2017
